MNPR
Monopar TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
MNPR vs peer average
66/100
MNPR vs. peer average (B vs. C)
Grade spread
A 1 · B 2 · C 2 · D 4
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
CADL is the first available peer comparator.
Same-sector, similar-market-cap candidate, but direct indication and program comparability are not established in the packet; weak comp.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MNPR
Monopar Therapeutics
CADL
Candel Therapeutics
Grade
B
C
Momentum
98
87
Value
41
41
Sentiment
51
38
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs CADL
MNPR / CADL
Grade Position
In line
MNPR vs. peer average (B vs. C)
66/100
Momentum
98
MNPRValue
41
MNPRSentiment
51
MNPRRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MNPR
CADL is the first peer returned for this comparison set.